Use of platelet reactivity testing in ACS patients coming off P2Y12 inhibitors who may be at risk for perioperative bleeding can safely shorten the waiting time before CABG, potentially cutting ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

Despite no slam-dunk evidence supporting the use of guided dual antiplatelet therapy (DAPT) strategies, either with platelet function or genotype testing, a new review paper argues that there’s still ...

Q: My platelets were slightly elevated on my blood test. What can cause this? A: Platelets are part of how our body forms clots to stop bleeding. They are produced in the bone marrow by cells called ...

When skin is cut or damaged, tiny cell fragments circulating in the blood, called platelets, arrive at the injury and spread out to stop the blood from leaking out. Once enough layers of platelets ...

Because leukemia is a blood cancer, it can affect a person’s platelet count. People with leukemia sometimes have a low platelet count. However, other conditions can also cause low platelets. Leukemia ...

November 15, 2009 (Orlando, Florida) — Results for the first head-to-head comparison of different platelet-function tests suggests that a handful of platelet reactivity assays--used to test the ...

(Ivanhoe Newswire) -- An analysis of six tests used to measure platelet function and gauge the effectiveness of anti-platelet drugs for patients undergoing a cardiac procedure such as a coronary stent ...

Earlier this year, a study conducted by the University of Edinburgh found that people who received the COVID-19 vaccine developed by AstraZeneca and the University of Oxford were at a very slightly ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Ochsner blood banks, like blood banks across ...

BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) ...